Ara
Toplam kayıt 3, listelenen: 1-3
Risk factors for recurrences in patients with hepatitis C virus after achieving a sustained virological response: A multicentre study from Turkey
(EDIMES Edizioni Medico Scientifiche, 2018)
In this study, we aimed to determine the late relapse rate in hepatitis C patients with sustained virological response after interferon-based regimens, and evaluated the predictors of late relapse while comparing the ...
HCV-specific lymphocyte responses in individuals with positive anti-HCV but negative HCV-RNA
(Elsevier Science, 2015)
Background: Hepatitis C virus (HCV) status cannot be reliably predicted in anti-HCV positive/HCV-RNA negative individuals who may either have recovered spontaneously or have a false-positive test due to antibody cross-reaction. ...
Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
(AVES, 2020)
Background/Aims: This study aimed to evaluate the real-life efficacy and tolerability of direct-acting antiviral treatments for patients with chronic hepatitis C (CHC) with/without cirrhosis in the Turkish population.Material ...